Mara Mirasoli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mara Mirasoli has a total of 281 co-authors. Here are the top co-authors by number of shared publications:
- Aldo Roda
Department of Chemistry “G. Ciamician”, University of Bologna, 40126 Bologna, Italy
76 shared publications - Martina Zangheri
Department of Chemistry “Giacomo Ciamician”, Alma Mater Studiorum, University of Bologna, Tecnopolo di Rimini, Via Dario Campana 71, I-47922 Rimini, Italy
40 shared publications - Massimo Guardigli
Department of Chemistry “Giacomo Ciamician”, Alma Mater Studiorum, University of Bologna, Via Francesco Selmi 2, I-40126 Bologna, Italy
40 shared publications - Elisa Michelini
Department of Chemistry “Giacomo Ciamician”, University of Bologna, Via P. Gobetti 85, 40129 Bologna, Italy
26 shared publications - Donato Calabria
Department of Chemistry “Giacomo Ciamician”, Alma Mater Studiorum, University of Bologna, Via Francesco Selmi 2, I-40126 Bologna, Italy
20 shared publications - Patrizia Simoni
Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, 40138 Bologna, Italy
20 shared publications
Latest Publications
- 1 November 2026
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Sensors Journal
- Vol. 26 (21) , 33434-33445
A CubeSat-Compatible Optothermal Sensing Platform for Biofilm Fluorescence Monitoring
- 1 November 2026
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Sensors Journal
- Vol. 26 (21) , 33434-33445
A CubeSat-Compatible Optothermal Sensing Platform for Biofilm Fluorescence Monitoring
- Open Access
- 27 October 2026
- Published by International Association of Physical Chemists (IAPC) in ADMET and DMPK
- Vol. 14
CRISPR/Cas12-powered electrochemical biosensor for chikungunya virus DNA detection using gold-modified screen-printed carbon electrodes
Background and purpose: Chikungunya virus (CHIKV) remains a health concern because its symptoms overlap with dengue and Zika, often leading to misdiagnosis. Conventional diagnostic methods, including viral isolation, enzyme-linked immunosorbent assay (ELISA) and reverse transcription-polymerase chain reaction (RT-PCR), are time-consuming, costly, and dependent on specialized laboratories. This study aimed to develop a rapid, selective, and sensitive electrochemical biosensor integrated with CRISPR/Cas12 for CHIKV DNA detection. Experimental approach: A CHIKV-specific guide RNA targeting a conserved region of the E1 gene was designed in silico and selected by specificity score (99.15) and E-value (1.7). The platform used a gold particle-modified screen-printed carbon electrode (SPCE/Au) functionalized with a ferrocene-labelled DNA reporter. The electrode was characterized electrochemically, and the biosensor was tested for its response to CHIKV DNA, its selectivity against dengue virus (DENV) and SARS-CoV-2, and its detection performance across target concentrations. Key results: Au deposition enhanced the electrochemical properties of the electrode. Recognition of CHIKV DNA activated the CRISPR/Cas12 complex, whose collateral cleavage of the reporter reduced the ferrocene oxidation signal. The biosensor exhibited a concentration-dependent response over 0.01 to 10 ppb, with a limit of detection of 0.92 ppb and a limit of quantification of 2.77 ppb. The biosensor showed excellent selectivity against CHIKV competitors. Conclusion: This work shows that combining CRISPR/Cas12 collateral cleavage with a ferrocene-labelled reporter on SPCE/Au enables rapid, selective, and sensitive CHIKV detection. Validation with clinical samples is still needed. The platform supports early diagnosis and disease surveillance, in line with Sustainable Development Goal (SDG) 3 (Good Health and Well-being).
- 27 October 2026
- Published by International Association of Physical Chemists (IAPC) in ADMET and DMPK
- Vol. 14
Open AccessCRISPR/Cas12-powered electrochemical biosensor for chikungunya virus DNA detection using gold-modified screen-printed carbon electrodes
Background and purpose: Chikungunya virus (CHIKV) remains a health concern because its symptoms overlap with dengue and Zika, often leading to misdiagnosis. Conventional diagnostic methods, including viral isolation, enzyme-linked immunosorbent assay (ELISA) and reverse transcription-polymerase chain reaction (RT-PCR), are time-consuming, costly, and dependent on specialized laboratories. This study aimed to develop a rapid, selective, and sensitive electrochemical biosensor integrated with CRISPR/Cas12 for CHIKV DNA detection. Experimental approach: A CHIKV-specific guide RNA targeting a conserved region of the E1 gene was designed in silico and selected by specificity score (99.15) and E-value (1.7). The platform used a gold particle-modified screen-printed carbon electrode (SPCE/Au) functionalized with a ferrocene-labelled DNA reporter. The electrode was characterized electrochemically, and the biosensor was tested for its response to CHIKV DNA, its selectivity against dengue virus (DENV) and SARS-CoV-2, and its detection performance across target concentrations. Key results: Au deposition enhanced the electrochemical properties of the electrode. Recognition of CHIKV DNA activated the CRISPR/Cas12 complex, whose collateral cleavage of the reporter reduced the ferrocene oxidation signal. The biosensor exhibited a concentration-dependent response over 0.01 to 10 ppb, with a limit of detection of 0.92 ppb and a limit of quantification of 2.77 ppb. The biosensor showed excellent selectivity against CHIKV competitors. Conclusion: This work shows that combining CRISPR/Cas12 collateral cleavage with a ferrocene-labelled reporter on SPCE/Au enables rapid, selective, and sensitive CHIKV detection. Validation with clinical samples is still needed. The platform supports early diagnosis and disease surveillance, in line with Sustainable Development Goal (SDG) 3 (Good Health and Well-being).
- Open Access
- 2 September 2025
- Published by Elsevier in Electrochimica Acta
- Vol. 541
Trident-shaped fully 3D-printed electrochemical sensor for real-time measurements
- 2 September 2025
- Published by Elsevier in Electrochimica Acta
- Vol. 541
Open AccessTrident-shaped fully 3D-printed electrochemical sensor for real-time measurements
- Open Access
- 8 April 2025
- Published by MDPI AG in Biosensors
- Vol. 15 (4) , 238
New Frontiers for the Early Diagnosis of Cancer: Screening miRNAs Through the Lateral Flow Assay Method
MicroRNAs (miRNAs), which circulate in the serum and plasma, play a role in several biological processes, and their levels in body fluids are associated with the pathogenesis of various diseases, including different types of cancer. For this reason, miRNAs are considered promising candidates as biomarkers for diagnostic purposes, enabling the early detection of pathological onset and monitoring drug responses during therapy. However, current methods for miRNA quantification, such as northern blotting, isothermal amplification, RT-PCR, microarrays, and next-generation sequencing, are limited by their reliance on centralized laboratories, high costs, and the need for specialized personnel. Consequently, the development of sensitive, simple, and one-step analytical techniques for miRNA detection is highly desirable, particularly given the importance of early diagnosis and prompt treatment in cases of cancer. Lateral flow assays (LFAs) are among the most attractive point-of-care (POC) devices for healthcare applications. These systems allow for the rapid and straightforward detection of analytes using low-cost setups that are accessible to a wide audience. This review focuses on LFA-based methods for detecting and quantifying miRNAs associated with the diagnosis of various cancers, with particular emphasis on sensitivity enhancements achieved through the application of different labels and detection systems. Early, non-invasive detection of these diseases through the quantification of tailored biomarkers can significantly reduce mortality, improve survival rates, and lower treatment costs.
- 8 April 2025
- Published by MDPI AG in Biosensors
- Vol. 15 (4) , 238
Open AccessNew Frontiers for the Early Diagnosis of Cancer: Screening miRNAs Through the Lateral Flow Assay Method
MicroRNAs (miRNAs), which circulate in the serum and plasma, play a role in several biological processes, and their levels in body fluids are associated with the pathogenesis of various diseases, including different types of cancer. For this reason, miRNAs are considered promising candidates as biomarkers for diagnostic purposes, enabling the early detection of pathological onset and monitoring drug responses during therapy. However, current methods for miRNA quantification, such as northern blotting, isothermal amplification, RT-PCR, microarrays, and next-generation sequencing, are limited by their reliance on centralized laboratories, high costs, and the need for specialized personnel. Consequently, the development of sensitive, simple, and one-step analytical techniques for miRNA detection is highly desirable, particularly given the importance of early diagnosis and prompt treatment in cases of cancer. Lateral flow assays (LFAs) are among the most attractive point-of-care (POC) devices for healthcare applications. These systems allow for the rapid and straightforward detection of analytes using low-cost setups that are accessible to a wide audience. This review focuses on LFA-based methods for detecting and quantifying miRNAs associated with the diagnosis of various cancers, with particular emphasis on sensitivity enhancements achieved through the application of different labels and detection systems. Early, non-invasive detection of these diseases through the quantification of tailored biomarkers can significantly reduce mortality, improve survival rates, and lower treatment costs.
- Open Access
Integrating Model-Based Systems Engineering into CubeSat Development: A Case Study of the BOREALIS Mission
The Biofilm Onboard Radiation Exposure Assessment Lab In Space (BOREALIS) mission is a 6U CubeSat initiative funded by the Italian Space Agency under the ALCOR program, executed through a collaboration among the School of Aerospace Engineering of Sapienza University of Rome, Interdepartmental Centre for Industrial Aerospace Research (CIRI Aerospace) of the University of Bologna and Kayser Italia Srl. BOREALIS is equipped with a lab-on-chip payload for studying the effects of microgravity and ionising radiation on microbial biofilms, which are crucial for understanding and preventing persistent infections in space environments. The satellite will operate across multiple orbits, moving from low to medium Earth orbit, to distinctly analyse the impacts of radiation separate from microgravity. The required orbital transfer not only tests the autonomy of its on-board systems in challenging conditions but also places BOREALIS among the first and few CubeSats to have ever attempted such a complex manoeuvre. This study explores the systematic application of Model-Based Systems Engineering to satellite design, from conceptualisation to trade-offs, using a tradespace analysis approach supported by Monte Carlo simulations to optimise mission configurations against performance and cost. Additionally, the adaptability of Model-Based Systems Engineering tools and the reusability of such an approach for other satellite projects are discussed, illustrating the BOREALIS mission as a case study for small mission design considering constraints and requirements.
Open AccessIntegrating Model-Based Systems Engineering into CubeSat Development: A Case Study of the BOREALIS Mission
The Biofilm Onboard Radiation Exposure Assessment Lab In Space (BOREALIS) mission is a 6U CubeSat initiative funded by the Italian Space Agency under the ALCOR program, executed through a collaboration among the School of Aerospace Engineering of Sapienza University of Rome, Interdepartmental Centre for Industrial Aerospace Research (CIRI Aerospace) of the University of Bologna and Kayser Italia Srl. BOREALIS is equipped with a lab-on-chip payload for studying the effects of microgravity and ionising radiation on microbial biofilms, which are crucial for understanding and preventing persistent infections in space environments. The satellite will operate across multiple orbits, moving from low to medium Earth orbit, to distinctly analyse the impacts of radiation separate from microgravity. The required orbital transfer not only tests the autonomy of its on-board systems in challenging conditions but also places BOREALIS among the first and few CubeSats to have ever attempted such a complex manoeuvre. This study explores the systematic application of Model-Based Systems Engineering to satellite design, from conceptualisation to trade-offs, using a tradespace analysis approach supported by Monte Carlo simulations to optimise mission configurations against performance and cost. Additionally, the adaptability of Model-Based Systems Engineering tools and the reusability of such an approach for other satellite projects are discussed, illustrating the BOREALIS mission as a case study for small mission design considering constraints and requirements.
- Open Access
- 4 January 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (1) , 414
Analysis of Glucocorticoids as Potential Adulterants in Cosmetic Products: A Dual Approach for Qualitative and Quantitative Evaluation Based on ELISA and HPLC-MS Methods
The analysis of cosmetic products represents an important field of analytical chemistry, since the demand for new formulations is continuously increasing. Regulations about prohibited/regulated compounds are applied in each country. Among the substances that are banned in cosmetics, corticosteroids represent a potential harm for consumers since the prolonged exposure to these compounds can affect health status. However, corticosteroids can be found in cosmetics as an illegal addition since they are able to alleviate the symptoms of inflammatory skin problems. In this work, two different approaches for detecting corticosteroids as potential adulterants in cosmetic products were compared. First, a reversed-phase HPLC-MS method was optimized and fully validated in order to identify and quantify eight corticosteroids (methylprednisolone, beclomethasone, flunisolide, budesonide, betamethasone 17-valerate, beclomethasone dipropionate, flumethasone, and dexamethasone). This reference method was then compared with an enzyme-linked immunosorbent assay (ELISA). Indeed, immunological techniques allow for rapid, low-cost, and sensitive detection of target analytes even in complex matrices, and they can be performed with simple instrumentation and by non-skilled personnel. The application of these methods on spiked cosmetic products was compared in terms of performance and advantages in order to evaluate the possibility of exploiting a complementary approach for optimizing the time for and costs of the analysis.
- 4 January 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (1) , 414
Open AccessAnalysis of Glucocorticoids as Potential Adulterants in Cosmetic Products: A Dual Approach for Qualitative and Quantitative Evaluation Based on ELISA and HPLC-MS Methods
The analysis of cosmetic products represents an important field of analytical chemistry, since the demand for new formulations is continuously increasing. Regulations about prohibited/regulated compounds are applied in each country. Among the substances that are banned in cosmetics, corticosteroids represent a potential harm for consumers since the prolonged exposure to these compounds can affect health status. However, corticosteroids can be found in cosmetics as an illegal addition since they are able to alleviate the symptoms of inflammatory skin problems. In this work, two different approaches for detecting corticosteroids as potential adulterants in cosmetic products were compared. First, a reversed-phase HPLC-MS method was optimized and fully validated in order to identify and quantify eight corticosteroids (methylprednisolone, beclomethasone, flunisolide, budesonide, betamethasone 17-valerate, beclomethasone dipropionate, flumethasone, and dexamethasone). This reference method was then compared with an enzyme-linked immunosorbent assay (ELISA). Indeed, immunological techniques allow for rapid, low-cost, and sensitive detection of target analytes even in complex matrices, and they can be performed with simple instrumentation and by non-skilled personnel. The application of these methods on spiked cosmetic products was compared in terms of performance and advantages in order to evaluate the possibility of exploiting a complementary approach for optimizing the time for and costs of the analysis.
- Open Access
- 28 May 2024
- Published by MDPI AG in Proceedings
- Vol. 104 (1) , 9
A Lab-on-Paper Biosensor for ATP Quantification via a Chemiluminescent DNA Nanoswitch Assay
Water is indispensable for life, yet many lack access to clean drinking water, resulting in fatalities from waterborne bacterial infections. Precise assessment of microbial abundance and viability in natural aquatic environments is vital. Adenosine triphosphate (ATP) serves as a parameter for viability assessments due to its presence in viable bacterial cells as an energy carrier. Traditional ATP detection methods involve chemical or enzymatic extraction, followed by measurement of light emission via the Luciferin–Luciferase complex. However, these methods are costly, present a low stability, require specialized equipment, and entail complex sample pretreatment. To overcome these limitations, we developed a biosensor based on aptamers, nucleic acid sequences with specific target-molecule-binding capabilities. Aptamers offer advantages such as an enhanced stability, a lower cost, and ease of design compared to antibodies. Recently, ATP has been used for aptamer selection testing. Our proposed biosensor utilizes a structure-switching ATP-binding DNA nanoswitch with two functional domains: a catalytic DNA-zyme domain and an ATP-binding aptamer domain. In the presence of ATP, its binding to the aptamer domain triggers the activation of the DNA-zyme domain, which is exploited for chemiluminescence (CL) detection. Integrating functional DNA biosensors with microfluidic paper-based analytical devices (µPADs) holds promise for point-of-care (POC) applications. However, achieving proper DNA binding on paper remains challenging, often requiring solution-based assay protocols, leaving µPADs for final signal readout. Here, we introduce an origami µPAD with preloaded dried reagents, allowing for on-paper assay execution upon sample addition and proper folding. Paper functionalization strategies and assay protocols were optimized to ensure simple and straightforward detection of ATP, employing a portable charge-coupled device (CCD) camera for CL detection. Calibration curves plotted against the logarithm of ATP concentration in the range of 1 to 500 µM facilitated determination of the assay’s limit of detection (LOD), which was found to be 3 µM.
- 28 May 2024
- Published by MDPI AG in Proceedings
- Vol. 104 (1) , 9
Open AccessA Lab-on-Paper Biosensor for ATP Quantification via a Chemiluminescent DNA Nanoswitch Assay
Water is indispensable for life, yet many lack access to clean drinking water, resulting in fatalities from waterborne bacterial infections. Precise assessment of microbial abundance and viability in natural aquatic environments is vital. Adenosine triphosphate (ATP) serves as a parameter for viability assessments due to its presence in viable bacterial cells as an energy carrier. Traditional ATP detection methods involve chemical or enzymatic extraction, followed by measurement of light emission via the Luciferin–Luciferase complex. However, these methods are costly, present a low stability, require specialized equipment, and entail complex sample pretreatment. To overcome these limitations, we developed a biosensor based on aptamers, nucleic acid sequences with specific target-molecule-binding capabilities. Aptamers offer advantages such as an enhanced stability, a lower cost, and ease of design compared to antibodies. Recently, ATP has been used for aptamer selection testing. Our proposed biosensor utilizes a structure-switching ATP-binding DNA nanoswitch with two functional domains: a catalytic DNA-zyme domain and an ATP-binding aptamer domain. In the presence of ATP, its binding to the aptamer domain triggers the activation of the DNA-zyme domain, which is exploited for chemiluminescence (CL) detection. Integrating functional DNA biosensors with microfluidic paper-based analytical devices (µPADs) holds promise for point-of-care (POC) applications. However, achieving proper DNA binding on paper remains challenging, often requiring solution-based assay protocols, leaving µPADs for final signal readout. Here, we introduce an origami µPAD with preloaded dried reagents, allowing for on-paper assay execution upon sample addition and proper folding. Paper functionalization strategies and assay protocols were optimized to ensure simple and straightforward detection of ATP, employing a portable charge-coupled device (CCD) camera for CL detection. Calibration curves plotted against the logarithm of ATP concentration in the range of 1 to 500 µM facilitated determination of the assay’s limit of detection (LOD), which was found to be 3 µM.
- Open Access
- 9 February 2024
- Published by MDPI AG in Chemosensors
- Vol. 12 (2) , 25
Easy-to-Use Chemiluminescent-Based Assay for a Rapid and Low-Cost Evaluation of the Antioxidant Activity of Cosmetic Products
New cosmetic formulations are continuously requested by the market and the ingredients are constantly evolving. Recently the use of antioxidants has gained success and, in this context, analytical methods able to quickly and easily assess the antioxidant activity of cosmetics would make it possible to carry out analyses on new formulations even within the manufacturing process without the need for specialized laboratories and personnel, thus evaluating directly on-site the effectiveness and the shelf life of products. In this work, a chemiluminescent inhibition assay was developed for determining the total antioxidant activity in cosmetic products. The method was based on the luminol/enhancers/hydrogen peroxide/horseradish peroxidase chemiluminescent system, which generates light signals measurable through simple and compact instrumentation. The formation of the chemiluminescent signal is inhibited by the presence of antioxidant substances while it is restored once all the antioxidant molecules have been oxidized. The time of appearance of the light signal is related to the total antioxidant activity. The assay was carried out exploiting an integrated device comprising a microwell plate coupled with an array of amorphous silicon hydrogenated photosensors enclosed in a mini-dark box. The method was optimized in terms of concentrations and volumes of the required reagents and sample pre-treatment. A calibration curve was generated taking as a reference the antioxidant activity of ascorbic acid obtaining a detection limit of 10 µM. The developed method was applied to cosmetic products currently on the market as well as on spiked samples in order to evaluate the performance of the methods in terms of sensitivity, accuracy, and reproducibility.
- 9 February 2024
- Published by MDPI AG in Chemosensors
- Vol. 12 (2) , 25
Open AccessEasy-to-Use Chemiluminescent-Based Assay for a Rapid and Low-Cost Evaluation of the Antioxidant Activity of Cosmetic Products
New cosmetic formulations are continuously requested by the market and the ingredients are constantly evolving. Recently the use of antioxidants has gained success and, in this context, analytical methods able to quickly and easily assess the antioxidant activity of cosmetics would make it possible to carry out analyses on new formulations even within the manufacturing process without the need for specialized laboratories and personnel, thus evaluating directly on-site the effectiveness and the shelf life of products. In this work, a chemiluminescent inhibition assay was developed for determining the total antioxidant activity in cosmetic products. The method was based on the luminol/enhancers/hydrogen peroxide/horseradish peroxidase chemiluminescent system, which generates light signals measurable through simple and compact instrumentation. The formation of the chemiluminescent signal is inhibited by the presence of antioxidant substances while it is restored once all the antioxidant molecules have been oxidized. The time of appearance of the light signal is related to the total antioxidant activity. The assay was carried out exploiting an integrated device comprising a microwell plate coupled with an array of amorphous silicon hydrogenated photosensors enclosed in a mini-dark box. The method was optimized in terms of concentrations and volumes of the required reagents and sample pre-treatment. A calibration curve was generated taking as a reference the antioxidant activity of ascorbic acid obtaining a detection limit of 10 µM. The developed method was applied to cosmetic products currently on the market as well as on spiked samples in order to evaluate the performance of the methods in terms of sensitivity, accuracy, and reproducibility.
- Open Access
- 30 January 2024
- Published by MDPI AG in Biosensors
- Vol. 14 (2) , 72
APHRODITE: A Compact Lab-on-Chip Biosensor for the Real-Time Analysis of Salivary Biomarkers in Space Missions
One of the main challenges to be faced in deep space missions is to protect the health and ensure the maximum efficiency of the crew by preparing methods of prevention and in situ diagnosis. Indeed, the hostile environment causes important health problems, ranging from muscle atrophy, osteopenia, and immunological and metabolic alterations due to microgravity, to an increased risk of cancer caused by exposure to radiation. It is, therefore, necessary to provide new methods for the real-time measurement of biomarkers suitable for deepening our knowledge of the effects of space flight on the balance of the immune system and for allowing the monitoring of the astronaut’s health during long-term missions. APHRODITE will enable human space exploration because it fills this void that affects both missions in LEO and future missions to the Moon and Mars. Its scientific objectives are the design, production, testing, and in-orbit demonstration of a compact, reusable, and reconfigurable system for performing the real-time analysis of oral fluid samples in manned space missions. In the frame of this project, a crew member onboard the ISS will employ APHRODITE to measure the selected target analytes, cortisol, and dehydroepiandrosterone sulfate (DHEA-S), in oral fluid, in four (plus one additional desired session) separate experiment sessions. The paper addresses the design of the main subsystems of the analytical device and the preliminary results obtained during the first implementations of the device subsystems and testing measurements on Earth. In particular, the system design and the experiment data output of the lab-on-chip photosensors and of the front-end readout electronics are reported in detail along with preliminary chemical tests for the duplex competitive CL-immunoassay for the simultaneous detection of cortisol and DHEA-S. Different applications also on Earth are envisaged for the APHRODITE device, as it will be suitable for point-of-care testing applications (e.g., emergency medicine, bioterrorism, diagnostics in developing countries, etc.).
- 30 January 2024
- Published by MDPI AG in Biosensors
- Vol. 14 (2) , 72
Open AccessAPHRODITE: A Compact Lab-on-Chip Biosensor for the Real-Time Analysis of Salivary Biomarkers in Space Missions
One of the main challenges to be faced in deep space missions is to protect the health and ensure the maximum efficiency of the crew by preparing methods of prevention and in situ diagnosis. Indeed, the hostile environment causes important health problems, ranging from muscle atrophy, osteopenia, and immunological and metabolic alterations due to microgravity, to an increased risk of cancer caused by exposure to radiation. It is, therefore, necessary to provide new methods for the real-time measurement of biomarkers suitable for deepening our knowledge of the effects of space flight on the balance of the immune system and for allowing the monitoring of the astronaut’s health during long-term missions. APHRODITE will enable human space exploration because it fills this void that affects both missions in LEO and future missions to the Moon and Mars. Its scientific objectives are the design, production, testing, and in-orbit demonstration of a compact, reusable, and reconfigurable system for performing the real-time analysis of oral fluid samples in manned space missions. In the frame of this project, a crew member onboard the ISS will employ APHRODITE to measure the selected target analytes, cortisol, and dehydroepiandrosterone sulfate (DHEA-S), in oral fluid, in four (plus one additional desired session) separate experiment sessions. The paper addresses the design of the main subsystems of the analytical device and the preliminary results obtained during the first implementations of the device subsystems and testing measurements on Earth. In particular, the system design and the experiment data output of the lab-on-chip photosensors and of the front-end readout electronics are reported in detail along with preliminary chemical tests for the duplex competitive CL-immunoassay for the simultaneous detection of cortisol and DHEA-S. Different applications also on Earth are envisaged for the APHRODITE device, as it will be suitable for point-of-care testing applications (e.g., emergency medicine, bioterrorism, diagnostics in developing countries, etc.).
- Open Access
- 4 January 2024
- Published by MDPI AG in Biosensors
- Vol. 14 (1) , 29
Microfluidic-Based Non-Invasive Wearable Biosensors for Real-Time Monitoring of Sweat Biomarkers
Wearable biosensors are attracting great interest thanks to their high potential for providing clinical-diagnostic information in real time, exploiting non-invasive sampling of biofluids. In this context, sweat has been demonstrated to contain physiologically relevant biomarkers, even if it has not been exhaustively exploited till now. This biofluid has started to gain attention thanks to the applications offered by wearable biosensors, as it is easily collectable and can be used for continuous monitoring of some parameters. Several studies have reported electrochemical and optical biosensing strategies integrated with flexible, biocompatible, and innovative materials as platforms for biospecific recognition reactions. Furthermore, sampling systems as well as the transport of fluids by microfluidics have been implemented into portable and compact biosensors to improve the wearability of the overall analytical device. In this review, we report and discuss recent pioneering works about the development of sweat sensing technologies, focusing on opportunities and open issues that can be decisive for their applications in routine-personalized healthcare practices.
- 4 January 2024
- Published by MDPI AG in Biosensors
- Vol. 14 (1) , 29
Open AccessMicrofluidic-Based Non-Invasive Wearable Biosensors for Real-Time Monitoring of Sweat Biomarkers
Wearable biosensors are attracting great interest thanks to their high potential for providing clinical-diagnostic information in real time, exploiting non-invasive sampling of biofluids. In this context, sweat has been demonstrated to contain physiologically relevant biomarkers, even if it has not been exhaustively exploited till now. This biofluid has started to gain attention thanks to the applications offered by wearable biosensors, as it is easily collectable and can be used for continuous monitoring of some parameters. Several studies have reported electrochemical and optical biosensing strategies integrated with flexible, biocompatible, and innovative materials as platforms for biospecific recognition reactions. Furthermore, sampling systems as well as the transport of fluids by microfluidics have been implemented into portable and compact biosensors to improve the wearability of the overall analytical device. In this review, we report and discuss recent pioneering works about the development of sweat sensing technologies, focusing on opportunities and open issues that can be decisive for their applications in routine-personalized healthcare practices.